Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mayer

Showing results (381-390 of 403) with videos related to

Pageof 41
Sort By:
Biorxiv : the Preprint Server for Biology|June 12, 2025
Engineering Sustained-Release Broadly Neutralizing Antibody FormulationsCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Nature Medicine|July 7, 2026
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trialDeborah A Theodore, Bryan T Mayer, Charlotte-Paige Rolle, et al.
Veterinaria Italiana|April 28, 2010
A Rift Valley fever risk surveillance system for Africa using remotely sensed data: potential for use on other continentsKenneth J Linthicum, Assaf Anyamba, Seth C Britch, et al.
Cell Host & Microbe|June 7, 2020
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape MutationsQiao Wang, Eleftherios Michailidis, Yingpu Yu, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Pharmaceutics|May 25, 2024
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIVBryan T Mayer, Lily Zhang, Allan C deCamp, et al.
Annals of the New York Academy of Sciences|August 23, 2018
Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacyWeidong Zhang, Adebayo J Molehin, Juan U Rojo, et al.
Epilepsy & Behavior : E&B|March 25, 2008
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 proceduresA Haag, S Knake, H M Hamer, et al.
Nature Immunology|August 16, 2011
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationMarc Beyer, Yasser Thabet, Roman-Ulrich Müller, et al.
Blood|December 28, 2020
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trialSilke Kapp-Schwoerer, Daniela Weber, Andrea Corbacioglu, et al.
Pageof 41

Showing results (381-390 of 403) with videos related to

Sort By:
Pageof 41
Biorxiv : the Preprint Server for Biology|June 12, 2025
Engineering Sustained-Release Broadly Neutralizing Antibody FormulationsCarolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Nature Medicine|July 7, 2026
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trialDeborah A Theodore, Bryan T Mayer, Charlotte-Paige Rolle, et al.
Veterinaria Italiana|April 28, 2010
A Rift Valley fever risk surveillance system for Africa using remotely sensed data: potential for use on other continentsKenneth J Linthicum, Assaf Anyamba, Seth C Britch, et al.
Cell Host & Microbe|June 7, 2020
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape MutationsQiao Wang, Eleftherios Michailidis, Yingpu Yu, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Pharmaceutics|May 25, 2024
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIVBryan T Mayer, Lily Zhang, Allan C deCamp, et al.
Annals of the New York Academy of Sciences|August 23, 2018
Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacyWeidong Zhang, Adebayo J Molehin, Juan U Rojo, et al.
Epilepsy & Behavior : E&B|March 25, 2008
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 proceduresA Haag, S Knake, H M Hamer, et al.
Nature Immunology|August 16, 2011
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationMarc Beyer, Yasser Thabet, Roman-Ulrich Müller, et al.
Blood|December 28, 2020
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trialSilke Kapp-Schwoerer, Daniela Weber, Andrea Corbacioglu, et al.
Pageof 41